Diagnostics company develops cancer test

2013-02-22 16:29:19

Empire Genomics LLC announced Nov. 1 that it will begin development of a new cancer test it said will help physicians select the right drug therapies based on the individual patients’ genetic markers.

The diagnostics company, based on the Buffalo Niagara Medical Campus, said the test will be the first proprietary therapeutic guiding test on the market to deliver precise treatment options for oncology patients with multiple myeloma and lymphoma, while bringing the company closer to delivering personalized medicines.

“Currently for this disease there is not a genetic test that allows physicians to understand what drug a patient will respond ...